ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
RXRX Stock Performance and Key Statistics
NASDAQ : RXRX
Recursion Pharmaceuticals, Inc.
$5.76
1.25+27.72%
At Close 4:00 PM$5.67
−0.09-1.56%
After-Market 08:30 PM73.23
BESG ScoreESG Rating
RXRX stock performance chart
Recursion Pharmaceuticals
The price of a stock is the truest depiction of a company's value and what the market anticipates about its performance. A stock's market value is critical, but the process is plagued with uncertainty, leading to investor skepticism. However, in today's economic environment, investors may learn a lot about the market expectations of their target stocks by looking at stock's performance and important indicators. Comparing their expectations to the market could help investors estimate their prospective return.
RXRX Fundamental Analysis
ATR0.68
Enterprise Value1.37B
Avg Vol (3 Months)24.78M
Avg Vol (10 Days)38.31M
RXRX Performance Chart
52-Week High12.36
52-Week High Chg-53.40%
52-Week Low3.79
52-Week Low Chg+51.98%
S&P 500 52-Week Chg3.16%
RXRX Technical Analysis
SMA 202.81%
SMA 50-16.38%
SMA 200-17.29%
RSI 1450.35
Performance
Period
High
Low
Performance
1 Week1 MonthQuarterHalf Year1 YearYTD66.9412.3612.3612.3612.363.793.793.793.793.793.79+35.85%-3.03%-16.28%-6.34%-32.87%-14.79%RXRX Industry Analysis and Valuation
Valuation
RXRX
Sector Median
Industry Avg
S&P 500
P/E (TTM)
P/S (TTM)
P/B (TTM)
P/FCF (TTM)
-4.18
38.7
1.87
-6.1
-1.24
3.77
1.01
-0.98
-5.18
467.43
-658.46
-180.6
32.59
5.98
4.86
20.78
Frequently Asked Questions
How is RXRX price-to-earnings ratio currently?
RXRX has a current P/E ratio of -4.18
How are RXRX's price-to-sale and price-to-book ratios?
The RXRX stock has a trailing twelve month price-to sales (P/S) ratio of 38.7 while its price-to-book (P/B) value is 1.87.
Is Recursion Pharmaceuticals, Inc.'s price-to-cashflow ratio high or low?
RXRX's price-to-free-cashflow (P/FCF) ratio is -6.1, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for RXRX?
Based on RXRX's recent bid, its distance from 20 days simple moving average is 2.81%. It is -16.38% apart from 50 days simple moving average, and it is -17.29% apart from 200 days simple moving average.
What is the 52-week price range for RXRX?
The 52-week high for RXRX is $12.36 which is -53.4% away from the current price level whereas the distance of that from the 52-week low of $3.79 stands at 51.98%.
An overview of RXRX's stock performance: how did it fare?
The performance of RXRX stock was not encouraging with most of its significant price indicators in red. Recursion Pharmaceuticals, Inc.(NASDAQ: RXRX) shares have moved upward +27.72% or $1.25 in the latest trading session and have lost -14.79% year-to-date (YTD). The stock has lost nearly -32.87% over the past year. After moving -16.28% over the trailing 3-month period, the stock is -6.34% lower in the 6-month period. Looking at its performance over the shorter term, it'sgained 35.85% a week and -3.03% a month.
What is RXRX's 14-day relative strength index (RSI)?
The current 14-day RSI for RXRX stock is 50.35. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For RXRX, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Recursion Pharmaceuticals, Inc. (RXRX) has a 14-day ATR of 0.68.
What is RXRX's current enterprise value?
After closing at $4.51 with 395.07M of its shares outstanding, the current enterprise value of RXRX is roughly 1.37B.
Over the past year, how has the stock price of RXRX changed?
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is down -32.87% when it comes to the percentage price change over the past 52-weeks. The percentage price change came less than that of broader S&P 500 index that came at a fall of 3.16%. RXRX stock price is also down -14.79% on its value in year-to-date trading.
What is the average trading volume for RXRX shares?
The number outstanding shares of RXRX is 395.07M, and of these 77.42% shares are freely available for trading. On average, RXRX stock has traded 38.31M shares per day for the past 10 days. A total of 83M shares changed hands during the last trading session with the average session volume of 24.07M shares.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep